American Society Of Transplant Surgeons
American Society Of Transplant Surgeons shows consistent revenue growth and stable assets with no reported officer compensation.
EIN: 133048373 · Arlington, VA · NTEE: G9BZ · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $11.8M |
| Total Expenses | $11.6M |
| Program Spending | 80% |
| Net Assets | $4.3M |
| Transparency Score | 85/100 |
Is American Society Of Transplant Surgeons Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
American Society Of Transplant Surgeons directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American Society Of Transplant Surgeons
American Society Of Transplant Surgeons (EIN: 133048373) is a nonprofit organization based in Arlington, VA, classified under NTEE code G9BZ. The organization reported total revenue of $11.8M and total assets of $6.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Society Of Transplant Surgeons's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Society Of Transplant Surgeons is a large nonprofit that has been operating for 51 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 9.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $11.5M |
| Total Expenses | $11.6M |
| Surplus / Deficit | $-74,804 |
| Total Assets | $6.6M |
| Total Liabilities | $2.3M |
| Net Assets | $4.3M |
| Operating Margin | -0.7% |
| Debt-to-Asset Ratio | 34.5% |
| Months of Reserves | 6.9 months |
Financial Health Grade: B
In 2023, American Society Of Transplant Surgeons reported a deficit of $75K with expenses exceeding revenue, holds 6.9 months of operating reserves (strong position), has a debt-to-asset ratio of 34.5% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), American Society Of Transplant Surgeons's revenue has grown at a compound annual growth rate (CAGR) of 9.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +4.9% | +9.1% | -8.8% |
| 2022 | +24.9% | +40.8% | +25.9% |
| 2021 | +40.3% | +41.5% | +33.2% |
| 2020 | +8.9% | -11.8% | +17.3% |
| 2019 | -6.5% | +-0.0% | +21.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1975 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Society Of Transplant Surgeons with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 80%
- fundraising: 5%
According to IRS 990 filings, American Society Of Transplant Surgeons allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $75K, with expenses exceeding revenue.
- Debt-to-asset ratio: 34.5%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, suggesting that executive leadership may be uncompensated or compensated through mechanisms not categorized as officer compensation on the 990, which is a positive indicator for resource allocation to mission.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of American Society Of Transplant Surgeons's IRS 990 filings:
- Lack of detailed functional expense breakdown on available data, making precise spending efficiency analysis difficult.
Strengths
The following positive indicators were identified for American Society Of Transplant Surgeons:
- Consistent and significant revenue growth over the past five years, from $5.7M in 2019 to $11.4M in 2023.
- Healthy and growing asset base, reaching $6.6M in 2023, indicating financial stability.
- Zero reported officer compensation across all available filings, suggesting strong resource allocation to mission.
- Generally positive net income in recent years (e.g., $360,518 surplus in 2022), demonstrating sound financial management.
- Consistent IRS 990 filing history, indicating good transparency practices.
Frequently Asked Questions about American Society Of Transplant Surgeons
Is American Society Of Transplant Surgeons a legitimate charity?
American Society Of Transplant Surgeons (EIN: 133048373) is a registered tax-exempt nonprofit based in Virginia. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $11.8M. 1 red flag identified. 5 strengths noted. Financial health grade: B.
How does American Society Of Transplant Surgeons spend its money?
American Society Of Transplant Surgeons directs 80% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to American Society Of Transplant Surgeons tax-deductible?
American Society Of Transplant Surgeons is registered as a tax-exempt nonprofit (EIN: 133048373). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of American Society Of Transplant Surgeons's spending goes to programs?
American Society Of Transplant Surgeons directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does American Society Of Transplant Surgeons compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), American Society Of Transplant Surgeons is above average for NTEE category G9BZ nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is American Society Of Transplant Surgeons located?
American Society Of Transplant Surgeons is headquartered in Arlington, Virginia and files with the IRS under EIN 133048373. It is classified under NTEE code G9BZ.
How many years of IRS 990 filings does American Society Of Transplant Surgeons have?
American Society Of Transplant Surgeons has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $11.8M in total revenue.
Is American Society Of Transplant Surgeons a good charity?
Based on the available financial data, ASTS appears to be a well-managed organization with consistent revenue growth, stable assets, and no reported officer compensation, suggesting a strong focus on its mission. Its financial health is robust.
How has ASTS's revenue changed over time?
ASTS has experienced significant revenue growth, nearly doubling from $5,732,977 in 2019 to $11,478,885 in 2023, indicating increasing support and activity.
What is the organization's asset position?
The organization maintains a healthy asset base, growing from $3,682,444 in 2019 to $6,606,925 in 2023, providing financial stability and capacity.
Does ASTS spend efficiently?
While a detailed functional expense breakdown is not provided, the consistent reporting of zero officer compensation and generally balanced revenue-to-expense ratios suggest efficient use of funds, with a presumed high allocation to program services.
Filing History
IRS 990 filing history for American Society Of Transplant Surgeons showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), American Society Of Transplant Surgeons's revenue has grown by 188.9%, moving from $4.0M to $11.5M. Total assets increased by 132% over the same period, from $2.8M to $6.6M. Total functional expenses rose by 182.7%, from $4.1M to $11.6M. In its most recent filing year (2023), American Society Of Transplant Surgeons reported a deficit of $75K, with expenses exceeding revenue. The organization holds $2.3M in liabilities against $6.6M in assets (debt-to-asset ratio: 34.5%), resulting in net assets of $4.3M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $11.5M | $11.6M | $6.6M | $2.3M | — | View 990 |
| 2022 | $10.9M | $10.6M | $7.2M | $2.8M | — | View 990 |
| 2021 | $8.8M | $7.5M | $5.8M | $1.7M | — | View 990 |
| 2020 | $6.2M | $5.3M | $4.3M | $1.5M | — | View 990 |
| 2019 | $5.7M | $6.0M | $3.7M | $1.7M | — | View 990 |
| 2018 | $6.1M | $6.0M | $3.0M | $800K | — | View 990 |
| 2017 | $4.9M | $5.6M | $3.1M | $937K | — | View 990 |
| 2016 | $5.6M | $5.1M | $3.5M | $615K | — | View 990 |
| 2015 | $5.0M | $5.5M | $2.7M | $629K | — | View 990 |
| 2014 | $5.1M | $5.4M | $3.2M | $682K | — | View 990 |
| 2013 | $5.1M | $5.4M | $3.4M | $644K | — | View 990 |
| 2012 | $5.0M | $4.4M | $3.5M | $379K | — | View 990 |
| 2011 | $4.0M | $4.1M | $2.8M | $355K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $11.5M, expenses of $11.6M, and assets of $6.6M (revenue +4.9% year-over-year).
- 2022: Revenue of $10.9M, expenses of $10.6M, and assets of $7.2M (revenue +24.9% year-over-year).
- 2021: Revenue of $8.8M, expenses of $7.5M, and assets of $5.8M (revenue +40.3% year-over-year).
- 2020: Revenue of $6.2M, expenses of $5.3M, and assets of $4.3M (revenue +8.9% year-over-year).
- 2019: Revenue of $5.7M, expenses of $6.0M, and assets of $3.7M (revenue -6.5% year-over-year).
- 2018: Revenue of $6.1M, expenses of $6.0M, and assets of $3.0M (revenue +26.1% year-over-year).
- 2017: Revenue of $4.9M, expenses of $5.6M, and assets of $3.1M (revenue -13.8% year-over-year).
- 2016: Revenue of $5.6M, expenses of $5.1M, and assets of $3.5M (revenue +12.6% year-over-year).
- 2015: Revenue of $5.0M, expenses of $5.5M, and assets of $2.7M (revenue -2.7% year-over-year).
- 2014: Revenue of $5.1M, expenses of $5.4M, and assets of $3.2M (revenue +1.1% year-over-year).
- 2013: Revenue of $5.1M, expenses of $5.4M, and assets of $3.4M (revenue +2.2% year-over-year).
- 2012: Revenue of $5.0M, expenses of $4.4M, and assets of $3.5M (revenue +25.3% year-over-year).
- 2011: Revenue of $4.0M, expenses of $4.1M, and assets of $2.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Society Of Transplant Surgeons:
Data Sources and Methodology
This transparency report for American Society Of Transplant Surgeons is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.